Tapewire

Nasdaq · USD

PCRX

Pacira BioSciences, Inc.

Export transactions ↓
Tapewire entity
4928
SEC CIK
0001396814
Parsed reports
428

Last 12 months

Inside the activity.

0 purchase rows · 17 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202502
Jan 202601
Feb 202602
Mar 202602
Apr 202604
May 202600
Jun 202602
Jul 202600
Aug 202601
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 06, 2022 Filed Jun 8, 2022 23:48 UTC
WINSTON ROYChief Medical Officer
SaleCommon Stock 123 $63.69 $7,833.87
Disclosure

SEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 10

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,160

F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.60 to $64.06, inclusive.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:48 UTC
WINSTON ROYChief Medical Officer
SaleCommon Stock 1,891 $62.48 $118,149.68
Disclosure

SEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 9

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,283

F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.200 to $62.935, inclusive.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:48 UTC
WINSTON ROYChief Medical Officer
SaleCommon Stock 3,650 $61.59 $224,803.50
Disclosure

SEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 8

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,174

F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.22 to $62.18, inclusive.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:48 UTC
WINSTON ROYChief Medical Officer
SaleCommon Stock 3,533 $60.55 $213,923.15
Disclosure

SEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 7

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,824

F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.220 to $61.215, inclusive.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:48 UTC
WINSTON ROYChief Medical Officer
SaleCommon Stock 115 $63.40 $7,291.00
Disclosure

SEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 6

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,357

F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.29 to $64.14, inclusive.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:48 UTC
WINSTON ROYChief Medical Officer
SaleCommon Stock 1,300 $62.43 $81,159.00
Disclosure

SEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 5

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,472

F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.23 to $62.78, inclusive.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:48 UTC
WINSTON ROYChief Medical Officer
SaleCommon Stock 2,300 $61.59 $141,657.00
Disclosure

SEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 4

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,772

F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.23 to $62.17, inclusive.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:48 UTC
WINSTON ROYChief Medical Officer
SaleCommon Stock 2,535 $60.55 $153,494.25
Disclosure

SEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 3

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,072

F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.23 to $61.22, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 3 through 10.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:48 UTC
WINSTON ROYChief Medical Officer
Exercise / conversionCommon Stock 6,250 $34.38 $214,843.75
Disclosure

SEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 2

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,607

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:48 UTC
WINSTON ROYChief Medical Officer
SaleCommon Stock 2,099 $61.37 $128,824.03
Disclosure

SEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 1

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,357

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:44 UTC
RIKER LAURENSenior Vice President, Finance
SaleCommon Stock 1,150 $61.37 $70,580.10
Disclosure

SEC source: 0001209191-22-035231 · doc4.xml · nonDerivative · entry 1

Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,002

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:40 UTC
REINHARDT MAXPresident, Rest of World
SaleCommon Stock 2,817 $61.37 $172,890.56
Disclosure

SEC source: 0001209191-22-035229 · doc4.xml · nonDerivative · entry 1

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,833

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:34 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
SaleCommon Stock 2,980 $61.37 $182,894.52
Disclosure

SEC source: 0001209191-22-035226 · doc4.xml · nonDerivative · entry 1

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,570

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:39 UTC
LARANJEIRA CHARLES ANTHONYChief Technical Officer
SaleCommon Stock 2,813 $61.37 $172,645.06
Disclosure

SEC source: 0001209191-22-035228 · doc4.xml · nonDerivative · entry 1

LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,789

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:31 UTC
McLoughlin DennisChief Customer Officer
SaleCommon Stock 2,140 $61.37 $131,340.36
Disclosure

SEC source: 0001209191-22-035225 · doc4.xml · nonDerivative · entry 1

McLoughlin Dennis · CIK 0001752004 · Chief Customer Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,820

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

F2 · balance_after: Includes 258 and 161 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021 and December 2021, respectively.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:24 UTC
GAUGLER DARYLChief Operating Officer
SaleCommon Stock 1,106 $61.37 $67,879.64
Disclosure

SEC source: 0001209191-22-035221 · doc4.xml · nonDerivative · entry 1

GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,494

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
May 23, 2022 Filed May 25, 2022 20:16 UTC
SLONIN JONATHANChief Clinical Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,000 $0.00 Strike: $52.37 $0.00
Disclosure

SEC source: 0001209191-22-031854 · doc4.xml · derivative · entry 2

SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,500

Underlying: Common Stock · 2,000 shares

Expires 2030-07-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
May 23, 2022 Filed May 25, 2022 20:16 UTC
SLONIN JONATHANChief Clinical Officer
Exercise / conversionCommon Stock 2,000 $52.37 $104,740.00
Disclosure

SEC source: 0001209191-22-031854 · doc4.xml · nonDerivative · entry 1

SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,559

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 209 shares of common stock acquired under the issuer's employee stock purchase plan in December 2021.

Read SEC document
May 09, 2022 Filed May 11, 2022 16:13 UTC SaleCommon Stock 1,000 $59.37 $59,370.00
Disclosure

SEC source: 0001209191-22-028275 · doc4.xml · nonDerivative · entry 1

Froimson Mark · CIK 0001709050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,908

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.36 to $59.41, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 28, 2022 Filed May 2, 2022 18:34 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $10.81 $0.00
Disclosure

SEC source: 0001209191-22-026483 · doc4.xml · derivative · entry 5

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,500 shares

Expires 2022-06-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.

Read SEC document
April 28, 2022 Filed May 2, 2022 18:34 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionCommon Stock 22,500 $10.81 $243,225.00
Disclosure

SEC source: 0001209191-22-026483 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,044

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
April 21, 2022 Filed Apr 25, 2022 20:12 UTC
REINHARDT MAXPresident, Rest of World
Exercise / conversionStock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $42.54 $0.00
Disclosure

SEC source: 0001209191-22-025516 · doc4.xml · derivative · entry 3

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 12,500 shares

Expires 2029-07-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
April 21, 2022 Filed Apr 25, 2022 20:12 UTC
REINHARDT MAXPresident, Rest of World
SaleCommon Stock 9,824 $73.25 $719,647.30
Disclosure

SEC source: 0001209191-22-025516 · doc4.xml · nonDerivative · entry 2

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,650

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · shares: Represents shares sold by the reporting person to cover the (i) exercise price of stock options and (ii) tax obligations due upon the exercise of such stock options.

Read SEC document
April 21, 2022 Filed Apr 25, 2022 20:12 UTC
REINHARDT MAXPresident, Rest of World
Exercise / conversionCommon Stock 12,500 $42.54 $531,750.00
Disclosure

SEC source: 0001209191-22-025516 · doc4.xml · nonDerivative · entry 1

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,474

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
April 20, 2022 Filed Apr 21, 2022 00:25 UTC
REINHARDT MAXPresident, Rest of World
Exercise / conversionStock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $42.54 $0.00
Disclosure

SEC source: 0001209191-22-025120 · doc4.xml · derivative · entry 9

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,500

Underlying: Common Stock · 12,500 shares

Expires 2029-07-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
April 20, 2022 Filed Apr 21, 2022 00:25 UTC
REINHARDT MAXPresident, Rest of World
SaleCommon Stock 9,764 $73.99 $722,438.36
Disclosure

SEC source: 0001209191-22-025120 · doc4.xml · nonDerivative · entry 6

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,974

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
April 20, 2022 Filed Apr 21, 2022 00:25 UTC
REINHARDT MAXPresident, Rest of World
Exercise / conversionCommon Stock 12,500 $42.54 $531,750.00
Disclosure

SEC source: 0001209191-22-025120 · doc4.xml · nonDerivative · entry 5

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,738

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
April 19, 2022 Filed Apr 21, 2022 00:25 UTC
REINHARDT MAXPresident, Rest of World
Exercise / conversionStock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $42.54 $0.00
Disclosure

SEC source: 0001209191-22-025120 · doc4.xml · derivative · entry 8

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 12,500 shares

Expires 2029-07-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
April 19, 2022 Filed Apr 21, 2022 00:25 UTC
REINHARDT MAXPresident, Rest of World
SaleCommon Stock 9,321 $72.25 $673,442.25
Disclosure

SEC source: 0001209191-22-025120 · doc4.xml · nonDerivative · entry 4

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,238

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · shares: Represents shares sold by the reporting person to cover the (i) exercise price of stock options and (ii) tax obligations due upon the exercise of such stock options.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.01 to $72.55, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
April 19, 2022 Filed Apr 21, 2022 00:25 UTC
REINHARDT MAXPresident, Rest of World
Exercise / conversionCommon Stock 12,500 $42.54 $531,750.00
Disclosure

SEC source: 0001209191-22-025120 · doc4.xml · nonDerivative · entry 3

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,559

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
April 18, 2022 Filed Apr 21, 2022 00:25 UTC
REINHARDT MAXPresident, Rest of World
Exercise / conversionStock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $42.54 $0.00
Disclosure

SEC source: 0001209191-22-025120 · doc4.xml · derivative · entry 7

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,500

Underlying: Common Stock · 12,500 shares

Expires 2029-07-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
April 18, 2022 Filed Apr 21, 2022 00:25 UTC
REINHARDT MAXPresident, Rest of World
SaleCommon Stock 8,941 $73.55 $657,610.55
Disclosure

SEC source: 0001209191-22-025120 · doc4.xml · nonDerivative · entry 2

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,059

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · shares: Represents shares sold by the reporting person to cover the (i) exercise price of stock options and (ii) tax obligations due upon the exercise of such stock options.

Read SEC document
April 18, 2022 Filed Apr 21, 2022 00:25 UTC
REINHARDT MAXPresident, Rest of World
Exercise / conversionCommon Stock 12,500 $42.54 $531,750.00
Disclosure

SEC source: 0001209191-22-025120 · doc4.xml · nonDerivative · entry 1

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 20:16 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 7,000 $0.00 Strike: $38.35 $0.00
Disclosure

SEC source: 0001209191-22-023856 · doc4.xml · derivative · entry 11

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,750

Underlying: Common Stock · 7,000 shares

Expires 2028-06-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 20:16 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $34.38 $0.00
Disclosure

SEC source: 0001209191-22-023856 · doc4.xml · derivative · entry 10

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 625

Underlying: Common Stock · 2,500 shares

Expires 2028-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 20:16 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $44.20 $0.00
Disclosure

SEC source: 0001209191-22-023856 · doc4.xml · derivative · entry 9

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2027-06-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 20:16 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 3,000 $0.00 Strike: $40.34 $0.00
Disclosure

SEC source: 0001209191-22-023856 · doc4.xml · derivative · entry 8

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,000 shares

Expires 2026-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 20:16 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
SaleCommon Stock 2,503 $77.94 $195,083.82
Disclosure

SEC source: 0001209191-22-023856 · doc4.xml · nonDerivative · entry 7

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,550

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.585 to $78.490, inclusive.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 20:16 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
SaleCommon Stock 3,937 $77.03 $303,267.11
Disclosure

SEC source: 0001209191-22-023856 · doc4.xml · nonDerivative · entry 6

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,053

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.58 to $77.57, inclusive.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 20:16 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
SaleCommon Stock 16,060 $76.03 $1,221,041.80
Disclosure

SEC source: 0001209191-22-023856 · doc4.xml · nonDerivative · entry 5

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,990

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.55 to $76.53, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 4.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 20:16 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
Exercise / conversionCommon Stock 7,000 $38.35 $268,450.00
Disclosure

SEC source: 0001209191-22-023856 · doc4.xml · nonDerivative · entry 4

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,050

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 20:16 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
Exercise / conversionCommon Stock 2,500 $34.38 $85,937.50
Disclosure

SEC source: 0001209191-22-023856 · doc4.xml · nonDerivative · entry 3

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,050

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 20:16 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
Exercise / conversionCommon Stock 10,000 $44.20 $442,000.00
Disclosure

SEC source: 0001209191-22-023856 · doc4.xml · nonDerivative · entry 2

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 20:16 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
Exercise / conversionCommon Stock 3,000 $40.34 $121,020.00
Disclosure

SEC source: 0001209191-22-023856 · doc4.xml · nonDerivative · entry 1

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
March 31, 2022 Filed Apr 5, 2022 17:26 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 22,500 $0.00 Strike: $10.81 $0.00
Disclosure

SEC source: 0001209191-22-023190 · doc4.xml · derivative · entry 5

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

Underlying: Common Stock · 22,500 shares

Expires 2022-06-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.

Read SEC document
March 31, 2022 Filed Apr 5, 2022 17:26 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionCommon Stock 22,500 $10.81 $243,225.00
Disclosure

SEC source: 0001209191-22-023190 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,544

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 20:37 UTC
WILLIAMS KRISTENChief Administrative Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,188 $0.00 Strike: $47.65 $0.00
Disclosure

SEC source: 0001209191-22-020788 · doc4.xml · derivative · entry 7

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,685

Underlying: Common Stock · 2,188 shares

Expires 2030-06-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 20:37 UTC
WILLIAMS KRISTENChief Administrative Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,112 $0.00 Strike: $43.54 $0.00
Disclosure

SEC source: 0001209191-22-020788 · doc4.xml · derivative · entry 6

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,560

Underlying: Common Stock · 2,112 shares

Expires 2029-06-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 20:37 UTC
WILLIAMS KRISTENChief Administrative Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,953 $0.00 Strike: $38.35 $0.00
Disclosure

SEC source: 0001209191-22-020788 · doc4.xml · derivative · entry 5

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,953

Underlying: Common Stock · 2,953 shares

Expires 2028-06-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 20:37 UTC
WILLIAMS KRISTENChief Administrative Officer
SaleCommon Stock 7,253 $72.67 $527,075.51
Disclosure

SEC source: 0001209191-22-020788 · doc4.xml · nonDerivative · entry 4

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,268

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.